DETAILED NOTES ON MBL77

Whereas minimal-rely MBL almost never progresses to CLL, high-rely MBL progresses to CLL demanding therapy at a fee of one% to two% per annum. Higher-count MBL is distinguished from Rai 0 CLL depending on if the B-cell rely is earlier mentioned or below five × 109/L. Despite the fact that persons with equally substantial-rely MBL and CLL Rai phase